
### [Orphanet:43](http://www.orpha.net/ORDO/Orphanet_43)
**Label:** X-linked adrenoleukodystrophy

**Subclasses:** [Orphanet:139399](http://www.orpha.net/ORDO/Orphanet_139399) (Adrenomyeloneuropathy), [Orphanet:139396](http://www.orpha.net/ORDO/Orphanet_139396) (X-linked cerebral adrenoleukodystrophy), 

**Corr. equiv. classes:** [Orphanet:139399](http://www.orpha.net/ORDO/Orphanet_139399), [OMIM:300100](http://purl.obolibrary.org/obo/OMIM_300100), [Orphanet:139396](http://www.orpha.net/ORDO/Orphanet_139396), 

**Class expressions from DL-Learner:**

- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0100639](http://purl.obolibrary.org/obo/HP_0100639) (Erectile abnormalities) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0031064](http://purl.obolibrary.org/obo/HP_0031064) (Impaired continence) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0031058](http://purl.obolibrary.org/obo/HP_0031058) (Impairment of activities of daily living) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0012874](http://purl.obolibrary.org/obo/HP_0012874) (Abnormal male reproductive system physiology) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0012700](http://purl.obolibrary.org/obo/HP_0012700) (Abnormal large intestine physiology) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0010985](http://purl.obolibrary.org/obo/HP_0010985) (Gonosomal inheritance) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0008207](http://purl.obolibrary.org/obo/HP_0008207) (Primary adrenal insufficiency) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) 66.67%
- [HP:0003455](http://purl.obolibrary.org/obo/HP_0003455) (Elevated long chain fatty acids) and [HP:0003676](http://purl.obolibrary.org/obo/HP_0003676) (Progressive) 66.67%


